Pages that link to "Q46589827"

The following pages link to The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation (Q46589827):

Displaying 27 items.

• Low-level laser therapy (LLLT) attenuates RhoA mRNA expression in the rat bronchi smooth muscle exposed to tumor necrosis factor-alpha (Q33555973) (← links)
• Role of PKC and RhoA/ROCK pathways in the spontaneous phasic activity in the rectal smooth muscle (Q33816566) (← links)
• Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation (Q34205274) (← links)
• Targeting Rho-GTPases in immune cell migration and inflammation (Q34803380) (← links)
• Role of Rho kinase isoforms in murine allergic airway responses. (Q35687203) (← links)
• Abrogation of airway hyperresponsiveness but not inflammation by rho kinase insufficiency (Q36057251) (← links)
• ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice (Q36122896) (← links)
• Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells (Q36142104) (← links)
• Proteomic analysis reveals the deregulation of inflammation-related proteins in acupuncture-treated rats with asthma onset (Q36471128) (← links)
• Airway smooth muscle in the pathophysiology and treatment of asthma (Q36787432) (← links)
• Emerging targets for novel therapy of asthma (Q36941412) (← links)
• Signaling through Rho GTPase pathway as viable drug target (Q37312315) (← links)
• Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration (Q37337818) (← links)
• Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease (Q37734257) (← links)
• Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. (Q37769931) (← links)
• Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones (Q38817408) (← links)
• Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. (Q38882099) (← links)
• Eosinophilic inflammation in allergic asthma. (Q39885996) (← links)
• Guinea pig models of asthma (Q46178349) (← links)
• Rho-kinase inhibition attenuates airway responsiveness, inflammation, matrix remodeling, and oxidative stress activation induced by chronic inflammation. (Q46240014) (← links)
• Effect of Rho-kinase inhibition on complexity of breathing pattern in a guinea pig model of asthma. (Q47130644) (← links)
• Role of ROCK2 in CD4+ cells in allergic airways responses in mice (Q48033800) (← links)
• New targets for resolution of airway remodeling in obstructive lung diseases. (Q55401303) (← links)
• Rho and Rac, but not ROCK, are required for secretion of human and mouse eosinophil-associated RNases (Q57180627) (← links)
• Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models (Q57470987) (← links)
• Effect of Anti-IL17 Antibody Treatment Alone and in Combination With Rho-Kinase Inhibitor in a Murine Model of Asthma (Q58762989) (← links)
• Rho signaling research: history, current status and future directions. (Q64884251) (← links)